US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 14.330
  • +0.420+3.02%
Close Sep 26 16:00 ET
  • 14.330
  • 0.0000.00%
Post 16:09 ET
661.00MMarket Cap10.69P/E (TTM)

Pacira BioSciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
-29.25%42.65M
Net income from continuing operations
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
-103.92%-693K
Operating gains losses
----
----
--16.93M
--0
--0
--0
62,588.89%16.93M
----
----
----
Depreciation and amortization
-1.00%18.86M
-6.00%18.43M
-17.41%75.57M
-39.21%18.49M
-8.74%18.43M
-8.68%19.05M
-2.15%19.6M
220.52%91.5M
132.64%30.41M
252.50%20.2M
Deferred tax
9.55%12.54M
147.17%3.46M
296.54%15.62M
160.89%6.6M
600.00%4.91M
428.74%11.44M
-25,417.24%-7.34M
-173.08%-7.95M
-420.90%-10.84M
-86.85%702K
Other non cash items
113.32%2.33M
-122.93%-3.03M
111.19%2.46M
121.19%854K
532.90%5.91M
11.14%-17.51M
1,522.48%13.21M
-205.97%-21.98M
-143.19%-4.03M
-82.56%933K
Change In working capital
29.39%-4.39M
151.59%8.11M
-178.57%-45.78M
-608.93%-15.65M
-846.02%-8.2M
-19.06%-6.21M
-93.04%-15.72M
12.00%-16.43M
-835.17%-2.21M
-105.64%-867K
-Change in receivables
46.54%-3.14M
-24.56%3.92M
-244.35%-7.16M
-74.56%-8.6M
189.73%2.12M
-688.68%-5.88M
23.18%5.19M
80.07%-2.08M
63.52%-4.93M
-112.87%-2.37M
-Change in inventory
-885.95%-6.66M
145.37%7.57M
-433.47%-8.29M
-1,165.71%-7.83M
-215.86%-4.39M
-72.45%847K
160.37%3.09M
155.65%2.49M
138.54%735K
294.81%3.79M
-Change in prepaid assets
9.70%-2.21M
146.57%897K
-257.13%-9.64M
-24.50%-2.65M
-198.20%-2.62M
-337.88%-2.44M
54.79%-1.93M
-336.34%-2.7M
-1,006.81%-2.13M
43.98%2.67M
-Change in payables and accrued expense
444.02%7.64M
84.42%-3.51M
-55.49%-21.12M
-42.48%3.05M
39.60%-3.08M
113.09%1.4M
-635.99%-22.49M
-182.37%-13.59M
-59.43%5.29M
-171.95%-5.1M
-Change in other current liabilities
86.71%-19K
-283.14%-771K
178.06%434K
133.42%394K
-265.28%-238K
-134.96%-143K
501.43%421K
-434.62%-556K
-162.32%-1.18M
113.95%144K
Cash from discontinued investing activities
Operating cash flow
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
-29.25%42.65M
Investing cash flow
Cash flow from continuing investing activities
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
-35.46%-47.52M
Net PPE purchase and sale
53.29%-1.59M
56.80%-2.84M
49.59%-15.16M
67.26%-1.8M
34.49%-3.39M
70.99%-3.4M
14.38%-6.57M
34.43%-30.08M
40.08%-5.49M
60.38%-5.18M
Net business purchase and sale
----
----
--0
----
----
----
----
--0
----
----
Net investment purchase and sale
-226.98%-13.63M
-117.45%-12.69M
156.83%92.7M
-39.02%10.17M
97.76%-948K
-65.27%10.73M
143.21%72.75M
-136.32%-163.11M
-96.66%16.68M
-92.42%-42.34M
Net other investing changes
----
----
----
----
----
----
----
-700.00%-32M
--0
--0
Cash from discontinued investing activities
Investing cash flow
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
-35.46%-47.52M
Financing cash flow
Cash flow from continuing financing activities
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
-354.75%-7.78M
Net issuance payments of debt
3,123.57%85.05M
98.09%-2.81M
57.74%-180.76M
95.26%-2.81M
-196.66%-27.81M
98.31%-2.81M
23.51%-147.33M
-217.58%-427.69M
-116.32%-59.38M
---9.38M
Proceeds from stock option exercised by employees
-58.07%1.36M
--0
-82.63%4.75M
-44.14%1.14M
-98.44%25K
-74.34%3.25M
-96.98%333K
2.57%27.34M
-66.20%2.04M
-47.58%1.6M
Net other financing activities
---36.44M
99.94%-4K
-497.36%-7.02M
---106K
--0
--0
---6.91M
87.90%-1.18M
----
----
Cash from discontinued financing activities
Financing cash flow
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
-354.75%-7.78M
Net cash flow
Beginning cash position
417.80%184.05M
47.21%153.3M
-82.22%104.14M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
485.83%585.58M
-18.36%109.42M
15.40%122.06M
Current changes in cash
22.89%63M
144.83%30.75M
110.21%49.16M
1,125.15%54.18M
197.40%12.31M
148.97%51.27M
80.88%-68.59M
-199.14%-481.44M
-101.17%-5.29M
-144.71%-12.64M
End cash Position
184.59%247.05M
417.80%184.05M
47.21%153.3M
47.21%153.3M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
-82.22%104.14M
-18.36%109.42M
Free cash flow
28.81%51.65M
268.26%46.27M
21.09%139.49M
25.29%45.79M
9.53%41.04M
121.87%40.1M
-45.64%12.56M
44.27%115.2M
160.13%36.55M
-20.63%37.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M-29.25%42.65M
Net income from continuing operations -26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M-103.92%-693K
Operating gains losses ----------16.93M--0--0--062,588.89%16.93M------------
Depreciation and amortization -1.00%18.86M-6.00%18.43M-17.41%75.57M-39.21%18.49M-8.74%18.43M-8.68%19.05M-2.15%19.6M220.52%91.5M132.64%30.41M252.50%20.2M
Deferred tax 9.55%12.54M147.17%3.46M296.54%15.62M160.89%6.6M600.00%4.91M428.74%11.44M-25,417.24%-7.34M-173.08%-7.95M-420.90%-10.84M-86.85%702K
Other non cash items 113.32%2.33M-122.93%-3.03M111.19%2.46M121.19%854K532.90%5.91M11.14%-17.51M1,522.48%13.21M-205.97%-21.98M-143.19%-4.03M-82.56%933K
Change In working capital 29.39%-4.39M151.59%8.11M-178.57%-45.78M-608.93%-15.65M-846.02%-8.2M-19.06%-6.21M-93.04%-15.72M12.00%-16.43M-835.17%-2.21M-105.64%-867K
-Change in receivables 46.54%-3.14M-24.56%3.92M-244.35%-7.16M-74.56%-8.6M189.73%2.12M-688.68%-5.88M23.18%5.19M80.07%-2.08M63.52%-4.93M-112.87%-2.37M
-Change in inventory -885.95%-6.66M145.37%7.57M-433.47%-8.29M-1,165.71%-7.83M-215.86%-4.39M-72.45%847K160.37%3.09M155.65%2.49M138.54%735K294.81%3.79M
-Change in prepaid assets 9.70%-2.21M146.57%897K-257.13%-9.64M-24.50%-2.65M-198.20%-2.62M-337.88%-2.44M54.79%-1.93M-336.34%-2.7M-1,006.81%-2.13M43.98%2.67M
-Change in payables and accrued expense 444.02%7.64M84.42%-3.51M-55.49%-21.12M-42.48%3.05M39.60%-3.08M113.09%1.4M-635.99%-22.49M-182.37%-13.59M-59.43%5.29M-171.95%-5.1M
-Change in other current liabilities 86.71%-19K-283.14%-771K178.06%434K133.42%394K-265.28%-238K-134.96%-143K501.43%421K-434.62%-556K-162.32%-1.18M113.95%144K
Cash from discontinued investing activities
Operating cash flow 22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M-29.25%42.65M
Investing cash flow
Cash flow from continuing investing activities -307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M-35.46%-47.52M
Net PPE purchase and sale 53.29%-1.59M56.80%-2.84M49.59%-15.16M67.26%-1.8M34.49%-3.39M70.99%-3.4M14.38%-6.57M34.43%-30.08M40.08%-5.49M60.38%-5.18M
Net business purchase and sale ----------0------------------0--------
Net investment purchase and sale -226.98%-13.63M-117.45%-12.69M156.83%92.7M-39.02%10.17M97.76%-948K-65.27%10.73M143.21%72.75M-136.32%-163.11M-96.66%16.68M-92.42%-42.34M
Net other investing changes -----------------------------700.00%-32M--0--0
Cash from discontinued investing activities
Investing cash flow -307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M-35.46%-47.52M
Financing cash flow
Cash flow from continuing financing activities 5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M-354.75%-7.78M
Net issuance payments of debt 3,123.57%85.05M98.09%-2.81M57.74%-180.76M95.26%-2.81M-196.66%-27.81M98.31%-2.81M23.51%-147.33M-217.58%-427.69M-116.32%-59.38M---9.38M
Proceeds from stock option exercised by employees -58.07%1.36M--0-82.63%4.75M-44.14%1.14M-98.44%25K-74.34%3.25M-96.98%333K2.57%27.34M-66.20%2.04M-47.58%1.6M
Net other financing activities ---36.44M99.94%-4K-497.36%-7.02M---106K--0--0---6.91M87.90%-1.18M--------
Cash from discontinued financing activities
Financing cash flow 5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M-354.75%-7.78M
Net cash flow
Beginning cash position 417.80%184.05M47.21%153.3M-82.22%104.14M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M485.83%585.58M-18.36%109.42M15.40%122.06M
Current changes in cash 22.89%63M144.83%30.75M110.21%49.16M1,125.15%54.18M197.40%12.31M148.97%51.27M80.88%-68.59M-199.14%-481.44M-101.17%-5.29M-144.71%-12.64M
End cash Position 184.59%247.05M417.80%184.05M47.21%153.3M47.21%153.3M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M-82.22%104.14M-18.36%109.42M
Free cash flow 28.81%51.65M268.26%46.27M21.09%139.49M25.29%45.79M9.53%41.04M121.87%40.1M-45.64%12.56M44.27%115.2M160.13%36.55M-20.63%37.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data